Learning outcomes – University of Copenhagen

Learning outcomes

The Master of Industrial Drug Development (MIND) programme equips graduates with the following knowledge, skills and competences:


MIND graduates have demonstrated knowledge and understanding of the following subjects:

  • target identification and validation methods and processes
  • lead optimisation methods and processes
  • principal steps and methodologies in drug discovery and development including translational steps
  • principal steps in discovering, modifying, assessing, producing and patenting new chemical and biological compounds
  • the overall development plan involving medicinal chemical, pharmaceutical, non-clinical and clinical development
  • quality assurance
  • regulation of medicines in the EU
  • management of drug safety issues before and after market authorisation
  • management of lifecycle activities (regulatory and marketing) of a medicine
  • ethical and legal provisions in drug development

MIND graduates have in-depth knowledge based on the highest level of international research in one or more subject areas in a selected field.  On this scientific basis, graduates are equipped to understand and reflect on the knowledge of the other subject areas and identify scientific issues.


MIND graduates are able to:

  • apply basic computational methods in the areas of bioinformatics and structure-based drug design
  • adhere to GMP and GCP guidelines for drug products
  • apply knowledge of drug regulatory affairs to work tasks and project strategies
  • schedule and integrate non-clinical tests into overall drug development and assess their predictive value
  • perform early studies in patients: dose-finding and proof-of-concept studies
  • design a confirmatory clinical development plan
  • perform a benefit/risk assessment throughout the lifecycle management of a medicine


MIND graduates are able to:

  • effectively and critically evaluate each stage of the drug development process and predict future bottlenecks
  • critically evaluate validation  of drug targets
  • manage and develop complex work situations related to drug discovery and development
  • critically evaluate chemical process development projects
  • independently initiate and carry out discipline-specific and interdisciplinary collaboration related to drug development
  • initiate, plan, implement and assume professional responsibility for drug development projects from discovery to clinical trials and registration
  • organise the elements of a drug development programme
  • liaise and communicate professionally, using scientific terminology, with other specialist groups within the drug development industry
  • take independent responsibility for own professional development.